Page last updated: 2024-11-06

2,5-dimethylisosorbide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2,5-Dimethylisosorbide is a chiral diol derived from isosorbide, a bicyclic sugar alcohol. It is a promising building block for the synthesis of various chiral compounds and materials. Its unique structure and properties make it a subject of interest for its potential applications in the fields of pharmaceuticals, polymers, and materials science. 2,5-Dimethylisosorbide is a versatile molecule for the synthesis of various chiral compounds, including pharmaceuticals, agrochemicals, and polymers. It is a renewable resource derived from biomass, making it an attractive alternative to petrochemical-based materials. Researchers are investigating its use in the development of new bio-based materials with improved properties. The synthesis of 2,5-dimethylisosorbide typically involves the reaction of isosorbide with an appropriate alkylating agent. Due to its chiral nature, it can be used to synthesize enantiomerically pure compounds, which is important in the pharmaceutical industry. It has shown potential as a plasticizer for polymers, enhancing their flexibility and durability. The high glass transition temperature and excellent dimensional stability of 2,5-dimethylisosorbide make it suitable for use in high-performance polymers. It is also studied for its potential application in the development of new drug delivery systems, particularly for targeted drug delivery.'

Cross-References

ID SourceID
PubMed CID62990
SCHEMBL ID301881
MeSH IDM0119549

Synonyms (38)

Synonym
dimethyl isosorbide ether
nsc-40727
nsc40727
5306-85-4
nsc44695
nsc-44695
isosorbide dimethyl ether, 98%
dimethyl isosorbide
(3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan
isosorbide dimethyl ether
I0390
AKOS016010544
nsc 40727
glucitol, 1,4:3,6-dianhydro-2,5-di-o-methyl-, d-
einecs 226-159-8
unii-sa6a6v432s
sorbitol, 1,4:3,6-dianhydro-2,5-di-o-methyl-
d-glucitol, 1,4:3,6-dianhydro-2,5-di-o-methyl-
2,5-dimethylisosorbide
1,4:3,6-dianhydro-2,5-di-o-methyl-d-glucitol
isosorbide, dimethyl ether
sa6a6v432s ,
nsc 44695
2,5-di-o-methyl-1,4:3,6-dianhydro-d-glucitol
d-glucitol, 1,4:3,6-dianhydro-2,5-di-o-methyl
(3r,3ar,6s,6ar)-3,6-dimethoxyhexahydrofuro[3,2-b]furan
dimethyl isosorbide [ii]
dimethyl isosorbide [inci]
SCHEMBL301881
MEJYDZQQVZJMPP-ULAWRXDQSA-N
(3r,3ar,6s,6ar)-3,6-dimethoxy-hexahydrofuro[3,2-b]furan
AC8407
Q5807233
AS-17682
DTXSID201019399
CS-0144267
HY-134524
PD160011

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The occluded vasoconstrictor assay was used to assess the effect of penetration enhancers on the topical bioavailability of a representative steroid, betamethasone 17-benzoate, with dimethylisosorbide (DMI) as a reference solvent."( Optimization of bioavailability of topical steroids: penetration enhancers under occlusion.
Barry, BW; Southwell, D; Woodford, R, 1984
)
0.27
" However, due to ALA's high polarity its dermal bioavailability is rather limited and thus, permeation enhancement of this active is of major interest in research."( Rheological characterization and permeation behavior of poloxamer 407-based systems containing 5-aminolevulinic acid for potential application in photodynamic therapy.
Müller-Goymann, CC; van Hemelrijck, C, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.56)18.7374
1990's3 (16.67)18.2507
2000's5 (27.78)29.6817
2010's9 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.88 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (16.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]